Sage Journals: Discover world-class research

Retricted access

Research article

First published 2017-6

A conceptual model for the development process of confirmatory adaptive clinical trials within an emergency research network

Samkeliso C Mawocha, Michael D Fetters, Laurie J Legocki [...]

Clinical Trials

Retricted access

Other

First published 2002-7

Report of a Workshop on Confirmatory Evidence to Support a Single Clinical Trial as a Basis for New Drug Approval *

Carl C. Peck, Jill Wechsler

Therapeutic Innovation & Regulatory Science

Free access

Brief report

First published 2018-5

The case for introducing pre-registered confirmatory pharmacological pre-clinical studies

Olivia Kiwanuka, Bo-Michael Bellander, Anders Hånell

Journal of Cerebral Blood Flow & Metabolism

Retricted access

Research article

First published 2025-8

Comparison of adaptive seamless Phase 2/3 designs for dose selection in clinical trials with multiple endpoints

Man Jin

Clinical Trials

Retricted access

Research article

First published 2006-6

Guidelines for data and safety monitoring for clinical trials not requiring traditional data monitoring committees

SCT Working Group on Data Monitoring, Dennis O Dixon, Ralph S Freedman [...]

Clinical Trials

Retricted access

Other

First published 2008-11

Confirm and Explore: A Stepwise Approach to Clinical Study Designs

Naitee Ting

Therapeutic Innovation & Regulatory Science

Retricted access

Other

First published 2010-5

From Adaptive Design to Modern Protocol Design for Drug Development: Part I. Editorial and Summary of Adaptive Designs Session at the Third FDA/DIA Statistics Forum

Sue-Jane Wang, Frank Bretz

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2015-12

Sample size adjustment based on promising interim results and its application in confirmatory clinical trials

YH Joshua Chen, Caiyan Li, KK Gordon Lan

Clinical Trials

Retricted access

Research article

First published 2014-9

Novel Statistical Designs for Phase I/II and Phase II Clinical Trials With Dose-Finding Objectives

Oleksandr Sverdlov, Weng Kee Wong

Therapeutic Innovation & Regulatory Science

Open access

Review article

First published 2021

Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer

Logan P Rhea, Jeanny B Aragon-Ching

Clinical Medicine Insights: Oncology

Search results